Latest Updates

CDC expands booster eligibility to include teens ages 12 to 15

  • Science
  • Coronavirus Coverage
CDC expands booster eligibility to include teens ages 12 to 15
CDC expands booster eligibility to include teens ages 12 to 15
Booster doses will be rolled out immediately.

FDA authorizes Pfizer’s COVID-19 booster for teens ages 12 to 15

  • Science
  • Coronavirus Coverage
FDA authorizes Pfizer’s COVID-19 booster for teens ages 12 to 15
FDA authorizes Pfizer’s COVID-19 booster for teens ages 12 to 15
The agency also shortened the interval between primary vaccination and a booster and authorized a third dose for immunocompromised children ages 5 to 11.

FDA authorizes Merck’s COVID-19 antiviral pill

  • Science
  • Coronavirus Coverage
FDA authorizes Merck’s COVID-19 antiviral pill
FDA authorizes Merck’s COVID-19 antiviral pill
The decision came a day after Pfizer’s antiviral drug became the first of its kind to be authorized in the U.S.

FDA authorizes Pfizer’s COVID-19 antiviral pill

  • Science
  • Coronavirus Coverage
FDA authorizes Pfizer’s COVID-19 antiviral pill
FDA authorizes Pfizer’s COVID-19 antiviral pill
The treatment is the first of its kind to be authorized in the U.S. It will be available for adults and children older than 12 who are at risk of severe disease.

Pfizer extends COVID-19 vaccine clinical trials for children under 5

  • Science
  • Coronavirus Coverage
Pfizer extends COVID-19 vaccine clinical trials for children under 5
Pfizer extends COVID-19 vaccine clinical trials for children under 5
The company says two doses of the vaccine did not generate an adequate immune response in children ages 2 to 5 its clinical trials.

FDA authorizes Pfizer booster doses for teens ages 16 and 17

  • Science
  • Coronavirus Coverage
FDA authorizes Pfizer booster doses for teens ages 16 and 17
FDA authorizes Pfizer booster doses for teens ages 16 and 17
Unlike the mix-and-match approach approved for older populations, the agency only authorized the shots for teens who originally received Pfizer’s vaccine.

U.S. confirms first case of Omicron variant in California

  • Science
  • Coronavirus Coverage
U.S. confirms first case of Omicron variant in California
U.S. confirms first case of Omicron variant in California
The White House says the patient was diagnosed after traveling from South Africa to San Francisco and is experiencing mild symptoms.

FDA authorizes COVID-19 vaccine boosters for all adults

  • Science
  • Coronavirus Coverage
FDA authorizes COVID-19 vaccine boosters for all adults
FDA authorizes COVID-19 vaccine boosters for all adults
Jabs will be available to roll out as soon as this weekend.

U.K. authorizes Merck COVID-19 antiviral pill

  • Science
  • Coronavirus Coverage
U.K. authorizes Merck COVID-19 antiviral pill
U.K. authorizes Merck COVID-19 antiviral pill
The country is the first to authorize the drug, which is the first shown to successfully treat COVID-19.

CDC director signs off on Pfizer’s COVID-19 vaccine for children ages 5 to 11

  • Science
  • Coronavirus Coverage
CDC director signs off on Pfizer’s COVID-19 vaccine for children ages 5 to 11
CDC director signs off on Pfizer’s COVID-19 vaccine for children ages 5 to 11
The U.S. is prepared to roll out doses to kids as soon as tomorrow.

FDA authorizes Pfizer’s vaccine for emergency use in kids ages 5 to 11

  • Science
  • Coronavirus Coverage
FDA authorizes Pfizer’s vaccine for emergency use in kids ages 5 to 11
FDA authorizes Pfizer’s vaccine for emergency use in kids ages 5 to 11
The U.S. is prepared to roll out doses to kids as soon as the CDC gives its final approval, which is expected to come early next week.

FDA panel recommends Pfizer vaccine for kids ages 5 to 11

  • Science
  • Coronavirus Coverage
FDA panel recommends Pfizer vaccine for kids ages 5 to 11
FDA panel recommends Pfizer vaccine for kids ages 5 to 11
Here’s the latest news on COVID-19 vaccine rollout.

Pfizer says its vaccine is 90.7 percent effective in kids ages 5 to 11

  • Science
  • Coronavirus Coverage
Pfizer says its vaccine is 90.7 percent effective in kids ages 5 to 11
Pfizer says its vaccine is 90.7 percent effective in kids ages 5 to 11
Here’s the latest news on COVID-19 vaccine rollout.

CDC clears the way for Moderna and Johnson & Johnson boosters

  • Science
  • Coronavirus Coverage
CDC clears the way for Moderna and Johnson & Johnson boosters
CDC clears the way for Moderna and Johnson & Johnson boosters
Here’s the latest news on COVID-19 vaccine rollout.

FDA authorizes Moderna and Johnson & Johnson boosters

  • Science
  • Coronavirus Coverage
FDA authorizes Moderna and Johnson & Johnson boosters
FDA authorizes Moderna and Johnson & Johnson boosters
Here’s the latest news on COVID-19 vaccine rollout.
Legal
  • Terms of Use
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • About Nielsen Measurement
  • Do Not Sell or Share My Personal Information
Our Sites
  • Nat Geo Home
  • Attend a Live Event
  • Book a Trip
  • Buy Maps
  • Inspire Your Kids
  • Shop Nat Geo
  • Visit the D.C. Museum
  • Watch TV
  • Learn About Our Impact
  • Support Our Mission
  • Masthead
  • Press Room
  • Advertise With Us
Join Us
  • Subscribe
  • Customer Service
  • Renew Subscription
  • Manage Your Subscription
  • Work at Nat Geo
  • Sign Up for Our Newsletters
  • Contribute to Protect the Planet
Follow us
National Geographic Logo - Home

© 1996–2015 National Geographic Society© 2015–2026 National Geographic Partners, LLC